These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17484912)

  • 21. No association of the CD45 77C>G transversion with inflammatory bowel disease in German patients.
    Thude H; Rebstock K; Blume J; Lutz B; Barz D
    Int J Immunogenet; 2008 Aug; 35(4-5):335-7. PubMed ID: 18680516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying susceptibility to inflammatory bowel diseases: a candidate gene approach, genome-wide association studies, or both?
    Pavli P; Summers KM
    J Gastroenterol Hepatol; 2008 Jan; 23(1):6-7. PubMed ID: 18171338
    [No Abstract]   [Full Text] [Related]  

  • 23. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
    Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease.
    Baumgart DC; Buning C; Geerdts L; Schmidt HH; Genschel J; Fiedler T; Gentz E; Molnar T; Nagy F; Lonovics J; Lochs H; Wiedenmann B; Nickel R; Witt H; Dignass A
    Digestion; 2007; 76(3-4):196-202. PubMed ID: 18174680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Molecular identification of the PSORS2 locus: mutations and polymorphisms in CARD14 gene].
    Dereure O
    Ann Dermatol Venereol; 2013 Jan; 140(1):65-6. PubMed ID: 23328365
    [No Abstract]   [Full Text] [Related]  

  • 26. Expression signatures, barriers and beyond: the role of oxidative stress in murine colitis and human inflammatory bowel disease revisited.
    Rosenstiel P; Schreiber S
    Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):496-9. PubMed ID: 18467906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The genetics of inflammatory bowel disease.
    Van Limbergen J; Russell RK; Nimmo ER; Satsangi J
    Am J Gastroenterol; 2007 Dec; 102(12):2820-31. PubMed ID: 17894847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The significance of the gut barrier in disease.
    Meddings J
    Gut; 2008 Apr; 57(4):438-40. PubMed ID: 18334657
    [No Abstract]   [Full Text] [Related]  

  • 29. Review article: Inflammatory bowel disease and genetics.
    Weersma RK; van Dullemen HM; van der Steege G; Nolte IM; Kleibeuker JH; Dijkstra G
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():57-65. PubMed ID: 18081650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does the search for large genomic rearrangements impact BRCAPRO carrier prediction?
    Capalbo C; Buffone A; Vestri A; Ricevuto E; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A; Giannini G
    J Clin Oncol; 2007 Jun; 25(18):2632-4; author reply 2634-5. PubMed ID: 17577048
    [No Abstract]   [Full Text] [Related]  

  • 31. Unravelling the pathogenesis of inflammatory bowel disease.
    Xavier RJ; Podolsky DK
    Nature; 2007 Jul; 448(7152):427-34. PubMed ID: 17653185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunopathogenesis of inflammatory bowel disease: current concepts.
    Bamias G; Cominelli F
    Curr Opin Gastroenterol; 2007 Jul; 23(4):365-9. PubMed ID: 17545770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunologic and molecular mechanisms in inflammatory bowel disease.
    Ince MN; Elliott DE
    Surg Clin North Am; 2007 Jun; 87(3):681-96. PubMed ID: 17560420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inflammatory bowel diseases: an immunological approach].
    Sepúlveda SE; Beltrán CJ; Peralta A; Rivas P; Rojas N; Figueroa C; Quera R; Hermoso MA
    Rev Med Chil; 2008 Mar; 136(3):367-75. PubMed ID: 18575665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene-gene interactions in inflammatory bowel disease: biological and clinical implications.
    Achkar JP; Fiocchi C
    Am J Gastroenterol; 2009 Jul; 104(7):1734-6. PubMed ID: 19436278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotype-phenotype analysis of the CXCL16 p.Ala181Val polymorphism in inflammatory bowel disease.
    Seiderer J; Dambacher J; Leistner D; Tillack C; Glas J; Niess JH; Pfennig S; Jürgens M; Müller-Myhsok B; Göke B; Ochsenkühn T; Lohse P; Reinecker HC; Brand S
    Clin Immunol; 2008 Apr; 127(1):49-55. PubMed ID: 18248772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The genetics and immunopathogenesis of inflammatory bowel disease.
    Cho JH
    Nat Rev Immunol; 2008 Jun; 8(6):458-66. PubMed ID: 18500230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
    van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of infection in inflammatory bowel disease: initiation, exacerbation and protection.
    Lidar M; Langevitz P; Shoenfeld Y
    Isr Med Assoc J; 2009 Sep; 11(9):558-63. PubMed ID: 19960852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysfunctional genomics: toward an integrative biology of disease and health--application to IBDs.
    Aronow BJ
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46 Suppl 1():E3-4. PubMed ID: 18354326
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.